
Meningococcal vaccine development in the United States began in the 1960s with the organization of a U.S. military meningococcal research group. Throughout both World Wars, meningococcal disease outbreaks occurred and...

The CDC recommends that the first dose of meningococcal conjugate vaccine targeting serogroups A, C, Y and W-135 (Menveo or MenQuadfi) be administered at age 11-12 with a second booster...

Individuals who take eculizumab (Soliris®), a medication often prescribed for paroxysmal nocturnal hemoglobinuria (PNH) or atypical hemolytic uremic syndrome, are also at a higher risk for the disease. Having a low...

Environmental and biological factors can also increase a person’s risk of developing meningococcal disease. Environmental factors include smoking or living with a smoker, alcohol consumption, and living in crowded environments...

In 1985, when the CDC’s Advisory Committee on Immunization Practices (ACIP) made its first recommendations on the recently licensed tetravalent meningococcal polysaccharide vaccine targeting serogroups A, C, Y, and W-135...

In 1952, public health officials reported infants to be four times more likely than school children and adults to develop meningococcal disease and that the disease was more likely to...

Between 1918 and 1928, horse antiserum was primarily used to treat meningococcal meningitis and public health officials reported that the antiserum was relatively successful in decreasing mortality rates from the...

Below are state statutes relating to minor consent for this state; however, there may be additional statutes NVIC is unaware of, and readers may need to do additional research and/or obtain...

Below are state statutes relating to minor consent for this state; however, there may be additional statutes NVIC is unaware of, and readers may need to do additional research and/or...

Below are state statutes relating to minor consent for this state; however, there may be additional statutes NVIC is unaware of, and readers may need to do additional research and/or...